rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Scott Moomaw

Chief Commercial Officer

Company insider

Files Form 4 as: Chief Commercial Officer, Liquidia.

Every Form 4 they filed

In numbers

Trades disclosed
144
Buys
1
Sells
29
Bought
$11K
Sold
$13.8M
Companies
1
Companies where not an officer
0
First trade
19 Nov 2020
Last trade
12 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
LQDA LiquidiaOfficer · Biotechnology · last 12 Oct 20261 buy · 29 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$252K8,863 at $28.48filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,108filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—4,358filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,108 at $0.00filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—4,358 at $0.00filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$48K675 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$634K8,864 at $71.52filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$48K675 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$634K8,864 at $71.52filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,108filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—4,358filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,108 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—4,358 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,108 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—4,358 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,108filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—4,358filing
13 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$340K8,861 at $38.37filing
13 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$64K1,686 at $38.20filing
13 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$340K8,861 at $38.37filing

Sectors

Health Care30

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Michael KasetaCFO and COO · CFO and COO at Liquidia, filing Form 4 there in the last year
Jason AdairChief Business Officer · Chief Business Officer at Liquidia, filing Form 4 there in the last year
Russell SchundlerGeneral Counsel · General Counsel at Liquidia, filing Form 4 there in the last year
Rajeev SaggarChief Medical Officer · Chief Medical Officer at Liquidia, filing Form 4 there in the last year
Dana BoyleChief Accounting Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days
Sarah KreppChief Human Resource Officer · Also traded LQDA in the last 90 days